Results 41 to 50 of about 28,266 (219)
Inappropriate thrombophilia tests ordered and cost.
Inappropriate thrombophilia tests ordered and cost.
Erafat Rehim (11457185) +6 more
core +1 more source
Indications and Efficacy of Progestogen‐Monotherapy as Menopause Hormone Therapy: A Narrative Review
ABSTRACT Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen monotherapy, though historically underutilized, represents a viable alternative in this population. This narrative review
Chloe Thomas +3 more
wiley +1 more source
The Authors Reply: “Cost and Utility of Thrombophilia Testing”
We thank Dr. Berse and colleagues for their correspondence about our paper. We are pleased they agreed with our conclusion: Thrombophilia testing has limited clinical utility in most inpatient settings.No Full ...
Petrilli, CM +9 more
core +1 more source
Background: Thrombophilia testing remains controversial, with no standardized recommendations across patient populations. Objectives: Given the clinical significance of high-risk thrombophilia (homozygous factor V Leiden or prothrombin G20210A mutations,
Shabnam Najaf Zadeh +8 more
doaj +1 more source
Abstract Topic This systematic review and meta‐analysis evaluated the association between retinal vein occlusion (RVO) and lymphoma across two complementary evidence components: a qualitative clinical synthesis of RVO occurring in patients with lymphoma and a quantitative synthesis of subsequent cancer outcomes in patients with RVO. For the qualitative
Kai‐Yang Chen +2 more
wiley +1 more source
Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley +1 more source
ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs), dual glucose‐dependent insulinotropic polypeptide (GIP)/GLP‐1RA and triple (GIP)/GLP‐1RA/glucagon agonists achieve placebo‐subtracted weight loss of 15% to 22%. Their long‐term value depends on how well the weight loss is maintained and on the composition of weight loss, not only
Michael Zitzmann +3 more
wiley +1 more source
Thrombophilia and the Placenta
This chapter contains sections titled: Introduction Inheritable thrombophilia Acquired thrombophilia Adverse pregnancy outcomes Thrombotic locations Diagnosis, management, and treatment ...
Paidas, Michael J +3 more
core +1 more source
Analysis of thrombophilia test ordering practices at king fahad hospital of the university
BACKGROUND: Thrombophilia tests are widely performed but often in a nonjustified and inappropriate manner as patients are not properly selected, or test timing is not considered.
Fatimah Adel Aldawood
doaj +1 more source
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto +12 more
wiley +1 more source

